Last Updated: August, 2024
Trusted by 200+ Clients
Compare & Choose the Right Report Version for You
How to Order Your Report?
The report provides a detailed analysis essential for establishing a Dostarlimab production plant. It encompasses all critical aspects necessary for Dostarlimab production, including the cost of Dostarlimab production, Dostarlimab plant cost, Dostarlimab production costs, and the overall Dostarlimab production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Dostarlimab production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Dostarlimab is a monoclonal antibody used in the treatment of different types of endometrial cancers and solid tumors. It works by attaching to a protein (PD-1) on the surface of immune cells. It stops the protein from interacting with other proteins, helping the immune system to recognize and attack cancer cells more efficiently. It is used to treat recurrent or advanced mismatch repair deficient (dMMR) endometrial cancers.
In different countries it is combined with other drugs like carboplatin and paclitaxel for treating dMMR or microsatellite instability-high (MSI-H) in adult patients. It is found to be effective for those patients who have no satisfactory alternative treatment options. It has shown great results for treating rectal cancer patients. Dostarlimab is also being explored for treating other cancers, such as colorectal, lung, gastric, prostate, and pancreatic cancers.
The Dostarlimab market is mainly driven by its use in treating different types of cancer. It is effective in treating recurrent or advanced dMMR endometrial cancers in adults, making it a sought-after drug in the medical field. Its use in combination with other drugs for treating dMMR and MSI-H in adults has contributed to its rising demand across the world.
Dostarlimab works as a successful alternative for those patients who are not responsive to other medications. Its effectiveness in treating rectal cancer and its potential use in treating several other cancers further contributes to its demand. The changes in its demand for medical applications, along with its production prices, market prices, and logistics, directly influence industrial Dostarlimab procurement in the market globally.
According to the Dostarlimab production plant project report, the key raw materials used in the production of Dostarlimab include Chinese Hamster Ovary (CHO) cells -Nutrients- Stabilizers- Excipients.
The extensive Dostarlimab production cost report consists of the following major industrial production processes:
Dostarlimab is an opalescent, colorless, pale-yellow liquid. Its molecular formula is C6420H9832N1690O2014S44, and it has a molar mass of approximately 144,325.73 g·mol?¹. It has a volume of distribution of about 5.3 L and a half-life of approximately 25.4 days. It is formulated containing 50 mg of the active ingredient per mL. It has a mean clearance at about 0.007 L/h at steady state. It works by minimizing effector functions, making it successful in clinical trials and reducing tumor size in patients with endometrial cancer. All these properties make it an efficient drug in cancer treatment.
Dostarlimab Production Cost Report
Choose What's Right for You
Pay Via
| Particulars | Details |
|---|---|
| Product Name | Dostarlimab |
| Scope | Production Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) |
| Pricing and Purchase Options | Basic: US$ 2499 Premium: US$ 3499 Enterprise: US$ 4799 |
| Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
At Procurement Resource, we not only focus on optimizing the should cost of production for Dostarlimab but also provide our clients with extensive intel and rigorous information on every aspect of the production process. By utilizing a comprehensive cost model, we help you break down expenses related to raw materials, labor, and technology, offering clear pathways to savings. We also assist in evaluating the capital expenditure (CAPEX) and operating expenses (OPEX), which are often measured as cost per unit of production, such as USD/MT, ensuring that your financial planning is aligned with industry benchmarks.
We offer valuable insights on the top technology providers, in-depth supplier database, and best manufacturers, helping you make informed decisions to improve efficiency. Additionally, we design the most feasible layout for your production needs, ensuring the entire process runs smoothly. By minimizing the cash cost of production, we ensure that you stay competitive while securing long-term profitability in the growing Dostarlimab market. Partnering with Procurement Resource guarantees that every aspect of your production is cost-efficient, advanced, and tailored to your specific requirements.
Vishakha Agrawal
Lead - Social & Development Research
Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.
Need more help?
Still Need Help?
